6Ozgunes I, Erben N, Kiremitci A, et al. The prevalence of extended-spectrum beta lactamase-producing Escherichia coli and Klebsiella pneumoniae in clinical isolates and risk factors. Saudi Med J, 2006,27:608-612.
7Gales AC, Menezes LC,Silbert S,et al. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta- lactamase. J Antimicrob Chemother,2003,52:699-702.
8Hosoglu S,Gundes S, Kolayli F, et al. Extended-spectrum beta- lactamases in ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae isolates in Turkish hospitals. Indian J Med Microbiol,2007,25:346-350.
9Pfaller MA, Segreti J. Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases. Clin Infect Dis,2006,42(Suppl 4):S153-S163.
10Rodriguez-Bano J, Navarro MD, Romero L, et al. Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coil in the CTX-M era: a new clinical challenge. Clin Infect Dis,2006,43:1407-1014.
